Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | NISCH | Q9Y2I1 | 2/20 | 0.33 |
| ▸ | STAT3 | P40763 | 1/20 | 0.33 |
| ▸ | STAT1 | P42224 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | ADK | P55263 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.33 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.33 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.33 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2955029 | 0.99 | IDO1 (0.36) | IDO1NISCHSTAT3STAT1MTOR | |
| SCHEMBL29834821 | 0.99 | IDO1 (0.36) | IDO1NISCHSTAT3STAT1MTOR | |
| SCHEMBL2963034 | 0.81 | NISCH (0.36) | IDO1NISCHSTAT3STAT1MTOR | |
| SCHEMBL31229595 | 0.79 | STAT3 (0.38) | STAT3STAT1 | |
| SCHEMBL2955031 | 0.78 | STAT3 (0.52) | IDO1NISCHSTAT3STAT1MTOR | |
| SCHEMBL31229735 | 0.77 | STAT3 (0.38) | STAT3STAT1 | |
| SCHEMBL11569705 | 0.77 | STAT3 (0.38) | IDO1STAT3STAT1ALDH1A1 | |
| SCHEMBL27596454 | 0.77 | STAT3 (0.38) | IDO1STAT3STAT1 | |
| SCHEMBL2963039 | 0.76 | STAT3 (0.50) | IDO1NISCHSTAT3STAT1MTOR | |
| SCHEMBL11326013 | 0.75 | METAP1 (0.40) | STAT3STAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117820657-A | Bimetallic site porphyrin nitrogen heterocyclic carbene coordination polymer and preparation method and application thereof | 安徽师范大学 | 2024-04-05 | — | — | CN | disclosed |
| EP-1690865-B1 | PORPHYRIN/PHTHALOCYANINE DIMER AND TETRAMER DIRECTLY BONDED AT PI SYSTEM AND PROCESSES FOR PRODUCING THESE | NAT UNIV CORP NARA INST (JP) | 2012-09-05 | — | — | EP | disclosed |
| US-7767808-B2 | for photoelectric conversion elements | National University Corporation NARA Institute of Science and Technology (JP) | 2010-08-03 | — | — | US | disclosed |
| US-20060217538-A1 | Porphyrin-phthalocyanine dimer and tetramer having directly-bound Pi electron systems and production method thereof | NATIONAL UNIVERSITY CORPORATION, NARA INSTITUTE OF SCIENCE AND TECHNOLOGY (JP) | 2006-09-28 | — | — | US | disclosed |
| EP-1690865-A1 | PORPHYRIN/PHTHALOCYANINE DIMER AND TETRAMER DIRECTLY BONDED AT PI SYSTEM AND PROCESSES FOR PRODUCING THESE | National University Corporation Nara Institute of Science and Technology (JP) | 2006-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060217538-A1 | Porphyrin-phthalocyanine dimer and tetramer having directly-bound Pi electron systems and production method thereof | CYC1, RRP12, PPOX | IDO1 790/4885NISCH 2190/4885STAT3 2160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.